Jim is the President and CEO of InnovateIP, an Intellectual Property Asset Management platform. Prior to joining InnovateIP, Jim was Assistant Vice President for Economic Development and the Executive Director of Commercialization and New Ventures at The University of Oklahoma where he taught Entrepreneurship and managed two technology investment funds.
Jim is an experienced entrepreneur and investor having spent over 15 years as a Venture Capitalist working with start-ups and university spin-outs. He has invested in and advised dozens of technology-based start-ups including QTera, Optium, Biofisica, Bladelogic, Digital Furnace, Moleculera and Lipid Biologics. He has led new company formations, follow-ons, strategic partnerships and exits as well as secondary investments in partnership funds. Most recently, Jim led an Atlanta-based IP search firm, IP2Biz, to a successful turnaround by implementing a new business strategy, company reorganization and financial recapitalization.
Jim began his career with BFGoodrich Aerospace managing operational and customer support resources for commercial airlines in Europe, Africa and the Middle East. He is an Eagle Scout, Scoutmaster, recipient of the Charles L. Sommers Triple Crown Award and an avid fly fisherman. He earned his MBA from Duke University and holds a BA in French and Economics from Sewanee: The University of the South.
[back to top]
Immediate Past-President and Past-Chair
At Rockwell Collins, Bill Elkington has provided leadership in multiple dimensions of IP management for the past 12 years including:
- The application of IP protection, valuation, business relationship, and transaction strategy to business strategy;
- Enterprise policy, procedure, training, tools, and change management strategies to protect IP and to enhance value extraction in business relationships; and
- The development and application of metrics and standards to the areas of IP protection and IP transactions.
Rockwell Collins is an aviation and high-integrity solutions company that supplies its commercial products and services to military customers world-wide.
Mr. Elkington has served on the LES (USA & Canada) Board of Trustees as the Public Policy/Regional VP, USA and is Co-chair of the LES Standards initiative, whose purpose is to develop standards for the field of IP management.
He also is a member of the Aerospace Industries Association, Intellectual Property Committee, where he works on education and policy issues with colleagues from other aerospace companies, specifically regarding software and data rights in Department of Defense contracting.
Mr. Elkington is regarded as a thought leader in the field of IP management, having written many articles for IAM Magazine and having been the subject of several round-table interview articles written by others for IAM. He is also a member of the IAM Strategy 300, an elite global group of IP strategists.
Prior to joining Rockwell Collins, Mr. Elkington was co-founder and VP of Program Management at MeshNetworks, a wireless startup company established to commercialize ITT's novel communications technology. MeshNetworks was sold to Motorola in 2004. Prior to joining MeshNetworks, he held positions in IP management, technology marketing, strategic and operations planning, and program management in ITT's Aerospace/Communications Division (A/CD) and General Electric R&D organizations.
[back to top]
President-Elect and Chair-Elect
Gary has served on the LES Board of Directors as Senior Vice President Meetings, Education and Strategic Alliances since 2016. Previously, he was the Trustee for Education: Webinars and has served as the Trustee for Sponsorship. Gary also served as President of the LES Foundation from 2014-2016 and Secretary from 2013-2014. Additionally, he was the Co-Chair of the 2012 Annual Meeting and one of the leaders responsible for the strong programming planned for the 2012 Annual Meeting. An active member of the High Tech Sector (HTS) for over ten years, Gary has served as Chair of the HTS Standards Committee, a facilitator at roundtable sessions and a frequent member of Annual Meeting planning committees.
Gary is a shareholder with the law firm of Banner & Witcoff, Ltd. He has practiced intellectual property (IP) law for over two decades. He has a broad base of experience in IP including involvement in all phases of the preparation and prosecution of patent applications before the USPTO, participating in patent infringement litigation in U.S. District Courts and post-issuance proceedings including preparation of IPRs. Also, Gary advises clients on IP issues including portfolio management, due diligence, validity and right-to-use opinions and licensing matters. In recent years, Gary has spoken on topics related to the America Invents Act (AIA).
Gary earned a B.S. in Computer and Systems Engineering from Rensselaer Polytechnic Institute and a J.D. from the George Washington University Law School.
[back to top]
Gillian M. Fenton is a seasoned senior executive with 30 years of experience in the biotechnology industry, including more than 23 years of experience as an IP strategist and biopharmaceuticals patent and transactions attorney. Gillian joined GSK Vaccines in April 2016 and is presently Senior Counsel, Vaccines Legal Operations – Innovation, Business Development and Strategic Alliances. Her responsibilities include managing GSK Vaccines' portfolio of R&D contracts with the U.S. Government, as well as leading in-bound and out-bound product and platform technology transactions for GSK's new U.S. Vaccines R&D Center in Rockville, MD. Prior to joining GSK, in September 2015, Gillian launched Fenton IP Solutions LLC, a specialty legal consulting firm delivering sophisticated, business-centric strategies for intellectual property and licensing matters to life sciences clients. In May 2015, Gillian was awarded a Corporate IP Star by Managing Intellectual Property Magazine. From 2006-2015, Gillian served as Vice President of Legal Affairs and Chief Intellectual Property Counsel at Emergent BioSolutions Inc. (NYSE: EBS), a global specialty biopharmaceutical firm. While at EBS, Gillian founded and built the IP department, a high functioning team of 8 patent professionals responsible for IP governance and compliance, as well as all aspects of IP strategy (asset management, freedom-to-operate risk mitigation, and value extraction). Gillian also oversaw all IP due diligence and other IP activities in support of EBS's M&A, and she also negotiated significant partnering, collaborative development, and asset disposition deals. In 2006, Gillian led all IP activities in support of EBS's initial public offering . From 1998-2003, Gillian was an Associate General Counsel for IP at Biogen Inc. (NASDAQ: BIIB), where she led all IP activities in support of BIIB's launch of its second biologic product, AMEVIVE® (alefacept). While at BIIB, Gillian also was the in-house team leader of a successful U.S. patent interference proceeding, which established BIIB's freedom to commercialize a humanized monoclonal antibody therapeutic agent for autoimmune disease and transplant indications. Gillian also has more than 11 years of experience in private practice at multiple leading Boston-based law firms. In her pre-law career, from 1985-1990, Gillian conducted research and immunoassay development at The Genetics Institute Inc., one of the founding companies of the U.S. biotechnology industry. Gillian has been a member of the Licensing Executives Society for more than 20 years and currently serves as Chair of the Editorial Board of LES Insights, the society's weekly newsletter. She earned a B.Sc. in Biochemistry at Trinity College, Hartford CT (1984) and a J.D. cum laude from the Suffolk University Law School, Boston MA (1992).
[back to top]
Annie Gauthier is a partner at the firm BCF and specializes in business law, mergers and acquisitions, and corporate law, and is one of the most respected lawyers in the field of technology and life sciences, and more specifically in the pharmaceutical industry.
With over 15 years' experience, Annie has practised with a nationally and internationally renowned law firm and worked on highly complex major transactions in addition to becoming one of the leading licensing experts in Canada.
Before joining BCF, Annie was Director, Transactions at Pharmascience, the largest employer in the pharmaceutical industry in Quebec. Working at this generics giant for over two years gave her inside understanding of the industry and an opportunity to conduct transactions on every continent. This experience makes her a top strategic advisor for her clients.
Annie is actively involved with her peers and her community, and was also the Chair of the Montreal chapter of the Licensing Executives Society for over five years before becoming a member of the board of directors for the North American region of the organization in 2016. In 2014, she co-founded L'étoffe du succès Montréal, an organization dedicated to helping women that is affiliated with Dress for Success Worldwide, where she still serves on the board of directors and as Vice-President.
[back to top]
President and Chair
Bob has been active in LES (USA & Canada) since 1998 having served in the following roles: Chair of the Aerospace and Transportation Subcommittee of the High Tech Sector (HTS) 2006-2007; Co-Chair and co-author of the HTS Royalty Rate and Deal Terms Surveys for 2011, 2014 & 2017; Secretary of the HTS 2011-2012; Vice-Chair of the HTS 2012-2013; Chair of the HTS 2013-2014; Workshop Chair for the 2012 HTS Winter Meeting; Program Chair for the 2012 LES Annual Meeting, and Program Chair for the 2013 LES Annual Meeting. Bob has served on the LES Board since 2012 in the following roles: Trustee for Content Creation, Capture and Delivery, VP of Education, and Regional Vice President, Policy, Standards, International & Strategic Planning. Bob currently holds the position of President-elect and Chair-elect of the LES Board of Directors. In addition, Bob has organized and presented workshops and mini-plenary sessions on a variety of IP topics, and is a frequent LES faculty member.
Bob is the President of Held Intellectual Property, LLC, and recently worked for TeleCommunication Systems, Inc. (TCS) in Annapolis, Maryland as the Vice President, Intellectual Asset Management, responsible for the strategic management and monetization of TCS's IP portfolio. All assets of TCS were acquired in February 2016. Immediately prior to joining TCS, Bob worked for Northrop Grumman Corporation, Electronic Systems Sector from 2003-2011 as the Director of the Intellectual Property & Strategic Technology Agreements business unit; and from 1998-2003 he worked at the IP firm British Technology Group (BTG) International.
Bob has been a Certified Licensing Professional (CLP) since 2008 and was named to the "IAM Strategy 300 - The World's Leading IP Strategists" in 2015, 2016, 2017, and 2018. Bob received his Bachelor of Science in Electrical Engineering degree from Villanova University and his MBA from Drexel University's LeBow College of Business.
[back to top]
Rachel has been a member of LES since 2002. She has been an active member of LES participating on the Public Policy Committee for the last several years. She currently serves as a Trustee at Large.
Rachel is Senior Assistant General Counsel for Purdue Pharma L.P. in Stamford, Connecticut. She manages patent litigation, primarily Hatch-Waxman cases, and settlements of patent litigation. She also is involved with IP licensing. After law school, Rachel went directly in house to Purdue. At the beginning of her career, her work was focused on licensing agreements to support Purdue's discovery research and other research groups, including licensing agreements with universities.
In 1999, Rachel received her B.S. in Chemistry with a minor in Management (concentrating on Entrepreneurship) from Rensselaer Polytechnic Institute. She attended Chicago-Kent College of Law in its Honors Scholars program and received a J.D. with a certificate in Intellectual Property in 2002. She is admitted to practice in the states of Connecticut and New York and the USPTO.
[back to top]
Louise is currently a consultant and active volunteer. She retired from ExxonMobil in 2017 after a career that included a diverse series of assignments. During her career she performed research in several different disciplines, supervised diverse research programs and held assignments in Planning and Analysis. She developed several research management systems, including one to promote cross functional research and one to manage ExxonMobil's entire upstream research program. After working with Intellectual Property as a scientist and supervisor for many years, Louise joined the Upstream Research Company's Commercial, Intellectual Property and Licensing group. She was responsible for IP processes, negotiating agreements and ensuring IP terms were consistent with the business needs, in all agreements, including sponsored research and licensing.
Since retirement Louise has joined the M. D. Anderson Venture Mentoring Service and has been mentoring new ventures across the University of Texas system. She recently had the opportunity to serve as the mentor for an M. D. Anderson team that was part of a national cohort for the NSF I-Corps program.
Louise has been an active member of LES, speaking at the local, national and international levels, and holding leadership positions, including Chapter Chair of the Houston Chapter. She has been active in the LES educational programs and has taught in many LES courses. She currently serves on the LES USA & Canada Board of Trustees as one of the two Directors of Local Chapters. Louise is a Certified Licensing Professional and an inventor on two patents. She holds a ScB degree in Geological Sciences from Brown University and MS and PhD degrees in Geochemistry from Stony Brook University.
[back to top]
Matthew McNeill is Chief Innovation Officer, VP of IP, Technology & Strategic Alliances at RiteHite. Matthew has overall responsibility for Innovation and Intellectual Property, including the licensing function, which has historically concentrated on in-licensing. He is also concentrated on business development through seeking and acquiring technology for the company. This can range from strategic supply agreements, to joint development, to IP licensing, to joint ventures to IP or corporate acquisition. He has also led business development efforts in emerging technology space in which "ultra-patentes" (beyond patent) strategies had to be employed to secure sustainable competitive advantage. Matthew has an undergraduate degree in Physics (Texas A&M) and a law degree (Boston College).
[back to top]
Annemarie Meike is a Business Development Executive having responsibility for commercialization of technologies and management of intellectual property portfolios for energy, environment, sensors, wireless technologies and nanomaterials at LLNL since 2000. Named by Intellectual Assets Magazine as one of the World's Leading IP Strategists, she negotiates business partnerships, and coaches and facilitates successful start-up companies, several of which have received prestigious R&D 100 awards. She also has engaged in business development and technical audits in the former Soviet Union, on behalf of the U.S. Department of Energy and the U.S. State Department. Annemarie has been recognized for excellence in technology licensing and the development of working partnerships by Santa Clara University, LLNL and the Federal Laboratory Consortium (FLC). Annemarie joined LLNL in 1989 to design, build and manage a multi-disciplinary scientific program predicting the ultra-long term degradation of materials, which she directed for 10 years. She was co-founder and organizing chair of the International Alloy Conferences, and sits on an Advisory Board of a National Science Foundation International Materials Institute. Annemarie holds a Ph.D. in Geology with an emphasis in Materials from University of California, Berkeley, and a J.D. from Santa Clara University. Annemarie has traveled widely, including research as a Senior Fulbright Fellow at Australian National University and teaching secondary school in Sierra Leone, West Africa. She has owned and directed two start-up companies, one in the U.S. and one in Australia. She is a member of several technical professional societies, and has held key leadership and founding roles in the Licensing Executives Society (LES) USA & Canada and the LES Foundation. She currently is Director of its International Graduate Student Business Plan Competition.
[back to top]
Lesley Millar-Nicholson, has been the Director of MIT Technology Licensing Office (TLO) since July 2016. She leads a team of professional staff managing the intellectual assets and technology transfer process for MIT's inventions. Located in Kendall Square the TLO is responsible for engagement with faculty, staff and students and for the efficient and effective transfer of IP into the market place to ensure impact in society. Working with MIT startup companies, VC's and corporate partners the team manage over 800 inventions a year from the MIT and Lincoln Lab campuses. The MIT portfolio includes over 2500 issued US patents, 1,000 active licenses with over 400 yielding revenue. The TLO is an integral part of the MIT innovation ecosystem working closely with the Industrial Liaison Program, Office of Sponsored Programs, the Deshpande Center, Sandbox Innovation Fund Program, Venture Mentoring Service, Martin Trust Entrepreneurship Center, MIT Innovation Initiative and many other programs and centers established to harness the amazing innovations from MIT faculty, students and staff. Prior to arriving in Cambridge Ms. Millar-Nicholson had served for ten years as Director of the Office of Technology Management (OTM) at the University of Illinois, Urbana/Champaign. Ms. Millar-Nicholson is the Immediate Past President of the Board of Governors of Certified Licensing Professionals Inc, (CLP Inc.), an active member of AUTM and the Licensing Executive Society. A native of Scotland, Ms. Millar-Nicholson has a B.Ed., M.Ed, MBA and is a Certified Licensing Professional.
[back to top]
Mike Pellegrino is the Founder and President of Pellegrino & Associates, LLC (P&A), a boutique intellectual property (IP) valuation firm. He has significant experience valuing patents and other forms of intellectual property, establishing royalty rates, and evaluating businesses. His company engagements number more than 400 for more than 200 clients, ranging from Fortune 100 companies like IBM, GE, State Farm, Liberty Mutual, American Express, and Lockheed Martin to startups. Judges, attorneys, and government entities such as the IRS and the SEC have widely accepted his work product. Courts at the state and federal level, tax jurisdictions, and arbitration panels have accepted Mike's work for issues including bankruptcy valuations, estate tax valuations, copyright infringement claims, trade secret misappropriation claims, patent infringement claims, breach of contract claims and others. One North Carolina court stated that Mike's work is "clearly in the mainstream of IP valuation methodologies" and that his qualifications were "outstanding."
Mike's experience positions him as a market leader in intangible asset valuation. He is the author of first and second editions of BVR's Guide to Intellectual Property Valuation, selling more than 700 books to a variety of customers including attorneys, tech transfer officers, business valuation firms, competing IP valuation firms, and more. In addition, his finance- and software-related articles appear in internationally and nationally recognized outlets, such as IAM Magazine, CFO Magazine, MSNBC.com, FoxNews.com, and others. Mike has had the pleasure of teaching thousands of people about valuations. Various venues around the globe, including law firms, universities, accounting firms, appraisal firms, valuation firms, state bar associations, and other organizations, frequently request his expertise at speaking engagements regarding intangible asset valuations and the tax effects of embedded application software and intellectual property.
His educational background includes a Bachelor's degree in computer science from Indiana Institute of Technology and a Master's degree in business administration from Ball State University. He also completed additional accounting coursework sufficient to fulfill the academic requirements for an undergraduate accounting degree. In addition, he completed both the 15-hour and 7-hour update USPAP training programs. He remains current with all USPAP training. Further training involves numerous ICLEF and NBI seminars on a variety of issues.
[back to top]
Paul A. Roberts
Paul Roberts is currently the LES Board Counsel (since 2016) and has been active in LES (USA & Canada) since 1996 and a Trustee since 2004, as well as a periodic LESI International Delegate. Previously, Paul was VP for Strategic & Long Range Planning, and he served as the Board Secretary for the maximum period of three years. Paul has also served as VP for Membership for three years, which includes responsibility for maintaining membership levels and increasing the number of new members, as well as overseeing LES' sponsorship activities. Paul has also been VP for Local Chapters during which he led a successful membership drive at the chapter level to increase new member percentage and convert non-member attendees to active members.
In another previous role as the Industrial Sector Trustee, Paul regularized sector interaction with the LES (USA & Canada) Board. Other positions and responsibilities included: Trustee for website matters, Chair for the High Technology Sector, Workshop and Add-On speaker, Meeting Chair for the Spring 2009 Meeting in Montreal, and Meeting Co-Chair for the 2008 Annual Meeting in Vancouver.
Paul is the Co-Founder and Chief IP Officer at Impact Engineered Wood, a start-up company that produces "green" building construction materials based on a revolutionary IP-protected and licensed technology. Previously, Paul was Co-Founder and Chief Patent counsel, Vice President of Licensing at Inventergy, an IP investment and licensing company designed to help technology leaders attain greater value from their IP assets. Paul was also Vice President of Patent Law & Commercialization at Rovi Corp, which successfully licenses its patented innovations in the areas of media guide and content delivery. Prior to that, Paul was the Lead Patent Legal Counsel at Accenture, as well as manager of patent acquisition through the merger of MCI with WorldCom and their Chapter 11 bankruptcy. He was also a United States Patent Examiner in the computer graphics area. He has been a member of the Association of Corporate Patent Counsels, as well as other IP professional associations.
Paul holds a BS in electrical engineering from Univ. of Maryland at College Park, and a law degree from Whittier Law School, in addition to an intellectual property certificate from Franklin Pierce Law School. Paul also has completed the Stanford Law (Board) Directors' College and achieved "fellowship" status through the National Association of Corporate Directors.
[back to top]
Kevin R. Spivak currently serves as Director Membership & Member Engagement on the LES Board of Directors and is a member of the intellectual property law firm of Vierra Magen Marcus LLP. Mr. Spivak's experience includes managing and securing intellectual property rights in a wide variety of technologies for domestic and global corporations.
Mr. Spivak represents major corporate clients in counseling, prosecuting and preparing both foreign and domestic patent applications, including filings via the Patent Cooperation Treaty. Mr. Spivak also advises in support of patent litigation and licensing negotiations, including cases before district and federal courts and the International Trade Commission (ITC), and prepares infringement, validity, freedom-to-operate and patentability opinions. He also conducts due diligence studies in all aspects of intellectual property.
The technologies involved in Mr. Spivak's daily practice include networks, telecommunications, mobile devices, VoIP, Internet telephony, power generation, semiconductors, optics, display technology, DVD technology and standards, gaming, automotive, computer hardware and software, and business methods.
Before completing law school, Mr. Spivak was a Patent Examiner in the USPTO, where he examined patent applications in computer-related technologies. Mr. Spivak received a B.S. in Computer Engineering from The George Washington University and a J.D. from The American University, Washington College of Law.
Specialties: Patent prosecution, including drafting and prosecuting applications before the USPTO; Due diligence; Data Mining and Landscaping; Opinions; Portfolio Management, Computer, Internet, Telecommunications and Business Method patents.
[back to top]
Eric Victory is Vice President & Head for cardiovascular, renal, metabolic, and infectious diseases within the Partnering & Strategy group at MedImmune, the biologics R&D unit for AstraZeneca, located in Gaithersburg, Maryland. In this role he is responsible for leading the company's early (pre-proof of concept) biologic externalization activities in two of our therapeutic areas, and for working with the CV/Renal/Metabolism and Microbial Sciences (Infectious Disease) Innovative Medicines Leadership Teams to drive and define the respective therapeutic area strategies within MedImmune. In this role, Eric has successfully closed the acquisitions of Spirogen and Amplimmune, brought on Sanofi Pasteur as a partner in developing MedImmune's MEDI8897 RSV antibody, and led key agreements with Inovio Pharmaceuticals, Omnis Pharmaceuticals, the Danish Diabetes Academy, the Joslin Diabetes Center, Shionogi, Advaxis, Immunocore, ADC Therapeutics, and NGM Biopharmaceuticals, all signed since the summer of 2013.
Prior to taking the Partnering and Strategy role in 2013, Eric was part of the MedImmune Corporate Development and Ventures team since 2011, with responsibility for business development and licensing transactions with university, academic, and non-profit institutions and in the cardiovascular, gastrointestinal, and metabolic disease therapeutic area, as well as oversight of MedImmune's pandemic influenza contracts with the United States Government. Eric joined MedImmune in 2002 as a Product Manager in MedImmune's Marketing Department and worked on Synagis (palivizumab), CytoGam (CMV-IVIG) and RespiGam (RSV-IVIG). In 2006 Eric joined MedImmune's Business Development Department where he has worked on licensing transactions across a range of therapeutic areas, including completing licenses with Trellis Biosciences, Immune Design Corporation, and Amgen, as well as out-licenses of MedImmune's reverse genetics intellectual property estates. Eric holds undergraduate degrees in physics and political sciences from Stanford University, and an MBA from Northwestern University's Kellogg School of Management.
Prior to his time at MedImmune, Eric was a commissioned officer in the United States Navy Nuclear Propulsion Program.
[back to top]
Scott is Director, Licensing at InterDigital, a leading mobile technology R&D company. Prior to joining InterDigital, Scott served as Director with Stout Risius Ross, Inc. (formerly Invotex) where he led the transaction services practice area. He was responsible for managing the sale and licensing of clients' intellectual property assets as well as providing consulting services related to both litigation and the valuation of intellectual property and technology businesses. Scott has more than 20 years of experience in licensing and business development as well as in consulting to technology businesses. Over the past fifteen years, he has specialized in intellectual property assets.
He also served as Vice President in the Strategic Business Development and Technology Commercialization business units of BTG plc, a British technology development and licensing company. Earlier in his career, Scott served as Director of Sales and Marketing for a start-up manufacturer of industrial computers and plant floor workstations where he was responsible for building a national distribution network and leading the company through a period of dynamic sales growth.
Scott received his BS in Mechanical Engineering from the University of Pittsburgh and his MBA from Temple University. He is also a Certified Licensing Professional and a Certified Valuation Analyst. Scott is an author and frequent speaker on licensing and IP valuation topics.
[back to top]